Drug profile · INN
fosaprepitant
FOSAPREPITANT MEDSURGE
fosaprepitant (FOSAPREPITANT MEDSURGE) is a neurokinin 1 receptor antagonist. Associated with Lacuna Pharma Pty Ltd.
EMA: approved TGA: approved Alimentary tract and metabolism (A04) A04AD12
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — fosaprepitant
- Class
- Alimentary tract and metabolism (A04)
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.83
Quick answer
fosaprepitant (FOSAPREPITANT MEDSURGE) is a neurokinin 1 receptor antagonist. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN fosaprepitant
Brand FOSAPREPITANT MEDSURGE
Mechanism Neurokinin 1 receptor antagonist
Therapeutic class Alimentary tract and metabolism (A04)
ATC code A04AD12
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Neurokinin 1 receptor antagonist
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | approved | — |
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is fosaprepitant?
fosaprepitant (FOSAPREPITANT MEDSURGE) is a neurokinin 1 receptor antagonist. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for fosaprepitant?
FOSAPREPITANT MEDSURGE is a marketed brand name for fosaprepitant. Check FDA Drugs@FDA for the current US label holder and prescribing information.